β1,4-N-acetylgalactosaminyltransferase III enhances malignant phenotypes of colon cancer cells
β1,4-N-acetylgalactosaminyltransferase III enhances malignant phenotypes of colon cancer cells
复制标题
DOI:
10.1158/1541-7786.mcr-06-0431
复制
发表时间:
2007-06-01
影响因子:
5.2
通讯作者:
Huang, Min-Chuan
中科院分区:
文献类型:
--
作者:
Huang, John;Liang, Jin-Tung;Huang, Min-Chuan
The enzyme 01,beta 1,4-N-acetylgalactosam i nyltransf erase III (beta 4GMNAc-T3) exhibits in vitro activity of synthesizing N,N '-diacetyllactosediamine, GaINAc beta 1,4GIcNAc. Here, we investigate the expression of beta 4GaINAc-T3 in primary colon tumors and the effects of its overexpression on HCT1 16 colon cancer cells. Real-time reverse transcription-PCR showed that the expression of beta 4GaINAc-T3 was up-regulated in 72.5% (n = 40) of primary colon tumors compared with their normal counterparts. beta 4GaINAc-T3 overexpression resulted in enhanced cell-extracellular matrix adhesion, migration, anchorage-independent cell growth, and invasion of colon cancer cells. Moreover, beta 4GaINAc-T3 overexpression increased tumor growth and metastasis and decreased survival of tumor-bearing nude mice. beta 4GaINAc-T3 overexpression showed increased tyrosine phosphorylation of focal adhesion kinase and paxillin Y118 as well as increased extracellular signal-regulated kinase phosphorylation. These results suggest that up-regulation of beta 4Ga1NAc-T3 may play a critical role in promoting tumor malignancy and that integrin and mitogen-activated protein kinase signaling pathways could be involved in the underlying mechanism.